CCJ
New cover, same uranium hype
Cameco just got a shiny new stamp of approval from William Blair, which kicked off coverage with an Outperform rating and a $165 fair value estimate. Translation: the firm thinks this uranium heavyweight still has room to run, and then some.
Why this matters
If you’ve been watching the uranium trade, you know this isn’t just about one stock getting a pat on the back. It’s another sign that the market’s “uranium supercycle” narrative is still very much alive — and Cameco sits near the center of that story like the kid everyone wants on their fantasy team.
The investor angle
For Cameco shareholders, fresh analyst coverage can matter because it helps keep the bull thesis in the spotlight and can pull in more momentum money. And with a price target/fair value estimate that implies serious upside from here, the message is basically: this isn’t being treated like a sleepy commodity miner anymore.
Big picture: when analysts start talking about supercycles, investors tend to perk up — because sometimes that’s the start of a long run, and sometimes it’s just Wall Street putting a fresh coat of paint on an old theme. Either way, CCJ just got a louder megaphone.